Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
Formats
RDF:
N-Triples
N3
Turtle
JSON
XML
OData:
Atom
JSON
Microdata:
JSON
HTML
Embedded:
JSON
Turtle
Other:
CSV
JSON-LD
Faceted Browser
Sparql Endpoint
About:
http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies
An Entity of Type:
Thing
,
from Named Graph:
http://dbpedia.org
,
within Data Space:
dbpedia.org
Property
Value
rdfs:
subClassOf
yago
:MonoclonalAntibody115029781
owl:
equivalentClass
yago-res
:wikicat_Monoclonal_antibodies
is
rdf:
type
of
dbr
:Canakinumab
dbr
:Cantuzumab_mertansine
dbr
:Cantuzumab_ravtansine
dbr
:Caplacizumab
dbr
:Carlumab
dbr
:Bence_Jones_protein
dbr
:Quilizumab
dbr
:Roledumab
dbr
:Rontalizumab
dbr
:Rovelizumab
dbr
:Samalizumab
dbr
:Sarilumab
dbr
:Basiliximab
dbr
:Bectumomab
dbr
:Belimumab
dbr
:Benralizumab
dbr
:Bertilimumab
dbr
:Besilesomab
dbr
:Bevacizumab
dbr
:Bezlotoxumab
dbr
:Bimagrumab
dbr
:Bivatuzumab
dbr
:Bivatuzumab_mertansine
dbr
:Blinatumomab
dbr
:Blosozumab
dbr
:Brentuximab_vedotin
dbr
:Briakinumab
dbr
:Denosumab
dbr
:Detumomab
dbr
:Anti-CD19_immunotoxin
dbr
:Anti-CD3_monoclonal_antibody
dbr
:Bi-specific_T-cell_engager
dbr
:Pateclizumab
dbr
:Pembrolizumab
dbr
:Perakizumab
dbr
:Pertuzumab
dbr
:Pexelizumab
dbr
:Reslizumab
dbr
:Rituximab
dbr
:Robatumumab
dbr
:Ublituximab
dbr
:Urtoxazumab
dbr
:Ustekinumab
dbr
:Vadastuximab_talirine_(SGN-CD33A)
dbr
:Vapaliximab
dbr
:Vatelizumab
dbr
:Vedolizumab
dbr
:Veltuzumab
dbr
:Vepalimomab
dbr
:Visilizumab
dbr
:Vorsetuzumab_mafodotin
dbr
:Ligelizumab
dbr
:Conatumumab
dbr
:Crenezumab
dbr
:Maslimomab
dbr
:Matuzumab
dbr
:Mavrilimumab
dbr
:Ruplizumab
dbr
:Chemically_linked_Fab
dbr
:Trifunctional_antibody
dbr
:Single-domain_antibody
dbr
:Atinumab
dbr
:Rabbit_hybridoma
dbr
:Citatuzumab_bogatox
dbr
:Cixutumumab
dbr
:Clazakizumab
dbr
:Clenoliximab
dbr
:Efalizumab
dbr
:Efungumab
dbr
:Eldelumab
dbr
:Elotuzumab
dbr
:Elsilimomab
dbr
:Enavatuzumab
dbr
:Enoticumab
dbr
:Ensituximab
dbr
:Epratuzumab
dbr
:Fresolimumab
dbr
:Galiximab
dbr
:Ganitumab
dbr
:Gantenerumab
dbr
:Gavilimomab
dbr
:Gemtuzumab_ozogamicin
dbr
:Gevokizumab
dbr
:Girentuximab
dbr
:Glembatumumab_vedotin
dbr
:Golimumab
dbr
:Minretumomab
dbr
:Mogamulizumab
dbr
:Monoclonal_antibody
dbr
:Morolimumab
dbr
:Moxetumomab_pasudotox
dbr
:Muromonab-CD3
dbr
:Namilumab
dbr
:Anifrolumab
dbr
:Anrukinzumab
dbr
:Apolizumab
dbr
:Lemalesomab
dbr
:Lerdelimumab
dbr
:Lexatumumab
dbr
:Libivirumab
dbr
:Lintuzumab
dbr
:Lirilumab
dbr
:Lorvotuzumab_mertansine
dbr
:Lucatumumab
dbr
:Lumiliximab
dbr
:Sibrotuzumab
dbr
:Sifalimumab
dbr
:Siltuximab
dbr
:Simtuzumab
dbr
:Siplizumab
dbr
:Demcizumab
dbr
:Yttrium_(90Y)_clivatuzumab_tetraxetan
dbr
:Yttrium_(90Y)_tacatuzumab_tetraxetan
dbr
:Zanolimumab
dbr
:Zolimomab_aritox
dbr
:Nomenclature_of_monoclonal_antibodies
dbr
:Vesencumab
dbr
:Bapineuzumab
dbr
:Brodalumab
dbr
:CR6261
dbr
:Catumaxomab
dbr
:Cedelizumab
dbr
:Certolizumab_pegol
dbr
:Cetuximab
dbr
:Tigatuzumab
dbr
:Tildrakizumab
dbr
:Tocilizumab
dbr
:Toralizumab
dbr
:Tositumomab
dbr
:Tralokinumab
dbr
:Trastuzumab
dbr
:Trastuzumab_emtansine
dbr
:Tregalizumab
dbr
:Tucotuzumab_celmoleukin
dbr
:Tuvirumab
dbr
:Peregrine_Pharmaceuticals
dbr
:3F8
dbr
:Abagovomab
dbr
:Abciximab
dbr
:Actoxumab
dbr
:Adalimumab
dbr
:Adecatumumab
dbr
:Aducanumab
dbr
:Alacizumab_pegol
dbr
:Alemtuzumab
dbr
:Alirocumab
dbr
:Amatuximab
dbr
:Anatumomab_mafenatox
dbr
:Dacetuzumab
dbr
:Daclizumab
dbr
:Dalotuzumab
dbr
:Daratumumab
dbr
:Drozitumab
dbr
:Dupilumab
dbr
:Dusigitumab
dbr
:Ecromeximab
dbr
:Eculizumab
dbr
:Edobacomab
dbr
:Edrecolomab
dbr
:Erlizumab
dbr
:Ertumaxomab
dbr
:Etaracizumab
dbr
:Etrolizumab
dbr
:Exbivirumab
dbr
:Faralimomab
dbr
:Farletuzumab
dbr
:Fasinumab
dbr
:Felvizumab
dbr
:Fezakinumab
dbr
:Ficlatuzumab
dbr
:Figitumumab
dbr
:Flanvotumab
dbr
:Fontolizumab
dbr
:Foralumab
dbr
:Foravirumab
dbr
:Nimotuzumab
dbr
:Nivolumab
dbr
:Otelixizumab
dbr
:Otlertuzumab
dbr
:Pagibaximab
dbr
:Palivizumab
dbr
:Panitumumab
dbr
:Pankomab
dbr
:Panobacumab
dbr
:Pascolizumab
dbr
:Guselkumab
dbr
:Intetumumab
dbr
:Ipilimumab
dbr
:Iratumumab
dbr
:Itolizumab
dbr
:Ixekizumab
dbr
:Talizumab
dbr
:Tanezumab
dbr
:Technetium_(99mTc)_arcitumomab
dbr
:Technetium_(99mTc)_sulesomab
dbr
:Tefibazumab
dbr
:Telimomab_aritox
dbr
:Tenatumomab
dbr
:Teneliximab
dbr
:Teplizumab
dbr
:Aselizumab
dbr
:Atorolimumab
dbr
:Abzyme
dbr
:Keliximab
dbr
:Labetuzumab
dbr
:Lampalizumab
dbr
:Lebrikizumab
dbr
:Bispecific_monoclonal_antibody
dbr
:Suvizumab
dbr
:Tadocizumab
dbr
:Duligotumab
dbr
:CBR96-doxorubicin_immunoconjugate
dbr
:Pidilizumab
dbr
:Placulumab
dbr
:Solanezumab
dbr
:Solitomab
dbr
:HuMax
dbr
:Human_anti-mouse_antibody
dbr
:Humanized_antibody
dbr
:IMAB362
dbr
:Ibalizumab
dbr
:Ibritumomab_tiuxetan
dbr
:Icrucumab
dbr
:Imgatuzumab
dbr
:Inclacumab
dbr
:Indatuximab_ravtansine
dbr
:Indium_(111In)_altumomab_pentetate
dbr
:Indium_(111In)_biciromab
dbr
:Indium_(111In)_capromab_pendetide
dbr
:Indium_(111In)_igovomab
dbr
:Indium_(111In)_satumomab_pendetide
dbr
:Inolimomab
dbr
:Inotuzumab_ozogamicin
dbr
:Mepolizumab
dbr
:Metelimumab
dbr
:Milatuzumab
dbr
:Narnatumab
dbr
:Natalizumab
dbr
:Nebacumab
dbr
:Necitumumab
dbr
:Nerelimomab
dbr
:Nesvacumab
dbr
:Obinutuzumab
dbr
:Ocaratuzumab
dbr
:Ocrelizumab
dbr
:Odulimomab
dbr
:Ofatumumab
dbr
:Olaratumab
dbr
:Olokizumab
dbr
:Omalizumab
dbr
:Onartuzumab
dbr
:Ontuxizumab
dbr
:Oportuzumab_monatox
dbr
:Orticumab
dbr
:Cancer_immunotherapy
dbr
:Cantuzumab
dbr
:Racotumomab
dbr
:Radretumab
dbr
:Rafivirumab
dbr
:Ramucirumab
dbr
:Ranibizumab
dbr
:Raxibacumab
dbr
:Regavirumab
dbr
:Sevirumab
dbr
:Neurovax
dbr
:Gomiliximab
dbr
:Enokizumab
dbr
:TNF_inhibitor
dbr
:Personalized_medicine
dbr
:Vorsetuzumab
dbr
:Single-chain_variable_fragment
dbr
:SGN-CD19A
dbr
:TGN1412
dbr
:Small_modular_immunopharmaceutical
This content was extracted from
Wikipedia
and is licensed under the
Creative Commons Attribution-ShareAlike 3.0 Unported License